Arosa Biotech Private Limited

Advanced Antioxidant Support with Pure Glutathione: AroGthione delivers high-quality glutathione, the body’s master antioxidant, which plays a critical role in neutralizing free radicals, reducing oxidative stress, and supporting cellular detoxification. Regular supplementation helps protect cells from damage and promotes overall well-being.

Promotes Skin Brightening and Liver Health: Widely known for its skin-lightening properties, glutathione helps reduce melanin production, leading to a brighter, more even skin tone. It also supports liver function by enhancing the body’s natural detox pathways, making it beneficial for individuals exposed to toxins, pollution, or unhealthy diets.

Convenient Daily Supplement for Immune and Anti-Aging Benefits: AroGthione is formulated for easy daily intake, helping to strengthen the immune system and slow signs of aging at the cellular level. Ideal for those seeking enhanced skin health, better energy levels, and stronger immune defense through consistent antioxidant support.

Oral Chemotherapy for Targeted Cancer Treatment: Arocbine contains capecitabine, an orally-administered chemotherapy drug that is converted into 5-fluorouracil (5-FU) in the body. It selectively targets and destroys rapidly dividing cancer cells, offering a convenient, non-invasive alternative to intravenous chemotherapy.

Clinically Proven for Multiple Cancer Types: Commonly used in the treatment of colorectal, breast, and gastric cancers, Arocbine is often prescribed as monotherapy or in combination with other anticancer agents. Its effectiveness and tolerability have made it a key component in both adjuvant and metastatic cancer treatment plans.

Convenient Oral Dosage with Controlled Absorption: Designed for patient-friendly administration, Arocbine allows for home-based treatment with fewer hospital visits. The tablets are formulated for controlled absorption, providing effective plasma levels of the active drug while minimizing systemic toxicity under proper medical supervision.

Targeted Therapy with Tyrosine Kinase Inhibition: Arotinib contains imatinib, a selective tyrosine kinase inhibitor that blocks abnormal proteins responsible for uncontrolled cancer cell growth. It is specifically designed to target and inhibit BCR-ABL, c-KIT, and PDGFR tyrosine kinases — key drivers in several cancers, enabling precise and effective treatment.

Proven Efficacy in Chronic and Acute Cancers: Widely used as a frontline treatment for chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) with Philadelphia chromosome positivity, as well as gastrointestinal stromal tumors (GISTs). Arotinib offers a well-established safety and efficacy profile backed by years of clinical data.

Oral Formulation for Long-Term Cancer Management: With a convenient oral dosage form, Arotinib supports daily self-administration, reducing dependency on hospital-based infusions. Its formulation is designed for consistent absorption and long-term use, helping patients maintain treatment adherence and quality of life during chronic therapy.

Aromatase Inhibitor for Hormone-Dependent Breast Cancer: Arostrozole contains anastrozole, a potent aromatase inhibitor that reduces estrogen production in the body. It is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women, helping to prevent cancer recurrence by depriving tumors of the hormones they need to grow.

Clinically Proven Adjuvant and First-Line Therapy: Arostrozole is widely prescribed as adjuvant therapy following surgery or radiation, and as first-line treatment for advanced or metastatic breast cancer. Its efficacy in improving disease-free survival has made it a standard of care in postmenopausal hormone-responsive breast cancer management.

Well-Tolerated Oral Therapy for Long-Term Use: Designed for once-daily oral administration, Arostrozole offers a convenient and manageable treatment option. It is generally well-tolerated, with fewer side effects compared to chemotherapy, making it suitable for long-term use under regular medical supervision.

Targeted EGFR Tyrosine Kinase Inhibitor for Lung Cancer: Geftirosa contains gefitinib, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor used primarily to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations. It works by blocking signals that promote cancer cell growth and survival.

Oral Administration for Convenient Treatment: Designed as an oral tablet, Geftirosa allows patients to receive targeted cancer therapy at home, reducing the need for frequent hospital visits and improving quality of life during treatment.

Clinically Proven to Improve Progression-Free Survival: Gefitinib has been shown in clinical trials to significantly delay disease progression in patients with EGFR-mutated NSCLC, making Geftirosa a vital option in personalized cancer therapy regimens.

Potent Anti-Inflammatory and Immunosuppressive Action: Dexarosa 8 contains 8 mg of dexamethasone, a powerful corticosteroid used to treat a wide range of inflammatory and autoimmune conditions. It works by suppressing the immune system’s response to inflammation, providing relief from swelling, redness, and allergic reactions.

Versatile Therapeutic Applications: This medication is indicated for use in conditions such as severe allergies, asthma, rheumatoid arthritis, skin diseases, and certain cancers. It is also commonly prescribed as part of supportive care in chemotherapy regimens and for managing adrenal insufficiency.

Clinically Trusted, High-Dose Formulation: Each tablet delivers a precise 8 mg dose, allowing for flexible and accurate dosing based on physician recommendations. Dexarosa 8 offers fast-acting and sustained relief, making it a trusted choice for short-term or long-term treatment protocols under medical supervision.

Effective Corticosteroid for Inflammation Control: Dexarosa 4 contains 4 mg of dexamethasone, a synthetic corticosteroid known for its potent anti-inflammatory and immunosuppressive effects. It helps manage a variety of conditions by reducing inflammation, allergic responses, and overactive immune reactions.

Suitable for a Wide Range of Medical Conditions: Commonly prescribed for diseases such as asthma, severe allergic reactions, autoimmune disorders (like lupus or rheumatoid arthritis), and certain types of cancer. It also plays a key role in managing adrenal insufficiency and reducing cerebral edema (brain swelling).

Precision Dosage for Flexible Treatment Plans: With a 4 mg strength per tablet, Dexarosa 4 allows for precise dosing adjustments tailored to individual treatment needs. Its intermediate dosage makes it ideal for tapering schedules or maintenance therapy under the guidance of a healthcare professional.